U.S. Stem Cell, Inc. Reports Most Successful Financial Performance in the Company’s History
Sunrise, FL – August 9, 2017 – U.S. Stem Cell, Inc., a Florida corporation, a leader in the regenerative medicine, cellular therapy industry providing physician based stem cell therapies to human and animal…
CEO Blog: Good Summer at USSC
Dear Shareholders and Friends, This past month has been one of great success here at U.S. Stem Cell Inc., starting with our CSO, Kristin Comella, being published both in the…
NBA Star John Salley partners with Stem Cell Centers of Excellence
West Palm Beach – Steve Nudelberg, Principal Thinker of On the Ball Ventures, is pleased to announce the partnership between John Salley and Stem Cell Centers of Excellence. On June…
U.S. Stem Cell to focus on and expand in-clinic therapies
Sunrise, FL – June 19, 2017 – (OTC:USRM) U.S. Stem Cell, Inc., a leader in the regenerative medicine, cellular therapy industry providing physician based stem cell therapies to human and animal patients as…
CEO Blog: May has been an exciting month
Dear shareholders and friends, May has been an exciting month with diverse accomplishments for U.S. Stem Cell, Inc. Our revenues continue to trend positive and all financial indicators are moving…
U.S. Stem Cell, Inc. Reports Continued Positive Results for Q1 2017
Sunrise, FL – May 3, 2017 – U.S. STEM CELL, Inc., a Florida corporation, a leader in the regenerative medicine, cellular therapy industry providing physician based stem cell therapies to…
CEO Blog: Exciting Accomplishments in April
Dear Shareholders and Friends, U.S. Stem Cell, Inc. has seen many exciting accomplishments in April. We have curated new partnerships, finalized investments, and received updates on our RMAT designation from…
General American Capital Partners invests up to $5 million in U.S. Stem Cell, Inc.
Sunrise, FL – April 13, 2017 – U.S. Stem Cell, Inc., a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and animal…
U.S. Stem Cell, Inc. MARVEL Trial Receives Reactivation Status with the FDA
Sunrise, FL – April 10, 2017 – U.S. Stem Cell, Inc. (USCC), a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and…
U.S. Stem Cell, Inc. and Advanced Stem Cell Rx Develop Strategic Alliance
Sunrise, FL – March 30, 2017 – U.S. Stem Cell, Inc. (USCC), a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and…
U.S. STEM CELL RELEASES POSITIVE 2016 FINANCIAL RESULTS
Sunrise, FL – March 15, 2017 – U.S. Stem Cell, Inc., a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and animal…
CEO Blog: U.S. Stem Cell, Inc. is off to a great start this year!
Dear shareholders and friends, U.S. Stem Cell, Inc. is off to a great start this year! We broke ground on our first clinic in the Middle East, presented at several…